March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (...
ACC
This channel contains news about the American College of Cardiology (ACC), including coverage of its annual meeting and links to recently released practice guidelines. The ACC is a leading resource for cardiology professionals, including all its subspecialties.
A CT study from the RESOLVE Trial showing valve leaflet thrombosis on a TAVR device. The trial examined a range of surgical and transcatheter valves to show thrombosis is found across both types of devices. It also examined if anticoagulation or antiplatelet therapy could reduce thrombosis and allow a greater range of leaflet motion.
Feature | Heart Valve Technology | March 21, 2017
March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood...
News | Cardiac Diagnostics | March 21, 2017
March 21, 2017 — A blood test for a protein called high-sensitivity troponin T, which is released into the...
Sponsored Content
An example of the new generation of inexpensive, wearable cardiac monitors that are seeing increased usage. This is the Cardiac Insight Cardea Solo device. After the monitoring period is over, the wearable patch is torn open to retrieve a data pod that is inserted into a reader to download the data. The software automatically creates reports based on the data, complete with waveforms for various cardiac measures.
Blog | Cardiac Diagnostics | May 10, 2018
Feature | Stents Bioresorbable | March 21, 2017 | Dave Fornell
March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College of...
Technology | Enterprise Imaging | March 20, 2017
March 20, 2017 — Agfa HealthCare announced the release a new version of its...
Technology | Cardiovascular Ultrasound | March 20, 2017
March 20, 2017 — Cardiologists can now access the advanced...
Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions.
Feature | FFR Technologies | March 20, 2017
March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR...
Feature | Pharmaceuticals | March 20, 2017
March 20, 2017 — The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology...
SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017.
News | Heart Valve Technology | March 17, 2017 | Dave Fornell
March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...
News | Cardiac Imaging | March 16, 2017
March 16, 2017 — During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC),...
Technology | Implantable Cardiac Monitor (ICM) | March 15, 2017
Medtronic Receives FDA Clearance for Reveal LINQ Insertable Cardiac Monitor With TruRhythm Detection
March 15, 2017 — Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Reveal...
Technology | Angiography | March 15, 2017
March 15, 2017 — The U.S. Food and Drug Administration (FDA) has cleared the Artis pheno robotic C-arm...
Technology | Heart Valve Technology | March 14, 2017
March 14, 2017 — The United States Food and Drug Administration (FDA) has expanded use of the Medtronic Melody...
Feature | Heart Valve Technology | March 14, 2017
March 14, 2017 — Transcatheter aortic valve replacement (TAVR) for aortic stenosis continues to evolve with the...
